Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biogen Inc (BIIB)

Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,427,562
  • Shares Outstanding, K 145,597
  • Annual Sales, $ 9,836 M
  • Annual Income, $ 1,161 M
  • 60-Month Beta -0.06
  • Price/Sales 2.79
  • Price/Cash Flow 10.22
  • Price/Book 1.73
Trade BIIB with:

Options Overview Details

View History
  • Implied Volatility 37.27% ( +1.19%)
  • Historical Volatility 19.67%
  • IV Percentile 90%
  • IV Rank 60.53%
  • IV High 47.65% on 07/25/24
  • IV Low 21.36% on 09/10/24
  • Put/Call Vol Ratio 0.90
  • Today's Volume 1,325
  • Volume Avg (30-Day) 3,059
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 51,163
  • Open Int (30-Day) 39,996

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 3.81
  • Number of Estimates 21
  • High Estimate 4.45
  • Low Estimate 3.38
  • Prior Year 4.36
  • Growth Rate Est. (year over year) -12.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.31 +3.90%
on 10/09/24
204.18 -7.74%
on 09/19/24
-10.71 (-5.38%)
since 09/11/24
3-Month
181.31 +3.90%
on 10/09/24
238.00 -20.85%
on 07/12/24
-48.42 (-20.45%)
since 07/11/24
52-Week
181.31 +3.90%
on 10/09/24
269.43 -30.08%
on 10/17/23
-78.14 (-29.32%)
since 10/11/23

Most Recent Stories

More News
These 3 Stocks Are Screaming Oversold: Seize the Opportunity

Micron, Biogen, and Regeneron are three stocks that appear oversold and could present substantial buying opportunities for investors seeking recovery plays.

MU : 106.92 (+1.16%)
REGN : 1,015.67 (+1.67%)
SPY : 579.58 (+0.60%)
BIIB : 188.38 (-0.11%)
Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

BIIB : 188.38 (-0.11%)
New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

IONS : 38.44 (+1.29%)
BIIB : 188.38 (-0.11%)
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030

It's hard to bet against this company right now.

LLY : 932.06 (+2.35%)
BIIB : 188.38 (-0.11%)
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with Disruptive Approaches to Treating Alzheimer’s Alzheimer’s...

ANVS : 7.93 (-0.88%)
LLY : 932.06 (+2.35%)
INMB : 5.14 (+2.39%)
XBI : 98.68 (+2.56%)
BIIB : 188.38 (-0.11%)
SAVA : 25.80 (+3.78%)
Is Biogen Stock Underperforming the Dow?

Biogen has underperformed the Dow over the past year, but analysts are moderately optimistic about the stock’s prospects.

$DOWI : 42,863.86 (+0.97%)
GILD : 84.95 (+0.33%)
BIIB : 188.38 (-0.11%)
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?

Eli Lilly and Company’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The stock has also outperformed the sector as well as the S&P 500 as seen in the chart...

BIIB : 188.38 (-0.11%)
NVO : 120.04 (+2.14%)
LLY : 932.06 (+2.35%)
Lilly Gets FDA Approval for Eczema Drug Ebglyss

Eli Lilly and Company LLY announced that the FDA has granted approval to its IL-13 inhibitor Ebglyss (lebrikizumab) for treating moderate-to-severe atopic dermatitis, also called eczema. Ebglyss is approved...

NVS : 116.22 (+1.23%)
BIIB : 188.38 (-0.11%)
PFE : 29.16 (-0.61%)
LLY : 932.06 (+2.35%)
Is Amgen Stock Outperforming the Nasdaq?

Amgen has surpassed the Nasdaq recently, and analysts are cautiously optimistic about its future potential.

AMGN : 328.35 (+2.29%)
$NASX : 18,342.94 (+0.33%)
BIIB : 188.38 (-0.11%)
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now

This competitive showdown just saw one of the players hit a couple of bumps.

BIIB : 188.38 (-0.11%)
LLY : 932.06 (+2.35%)
NVO : 120.04 (+2.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement...

See More

Key Turning Points

3rd Resistance Point 192.09
2nd Resistance Point 190.76
1st Resistance Point 189.57
Last Price 188.38
1st Support Level 187.05
2nd Support Level 185.72
3rd Support Level 184.53

See More

52-Week High 269.43
Fibonacci 61.8% 235.77
Fibonacci 50% 225.37
Fibonacci 38.2% 214.97
Last Price 188.38
52-Week Low 181.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar